Indicators

Indicator of the consequence of the crisis on the availability of the health services 

Indicator of support by health cluster partners beside MoH to the health system; in very disrupted health system can be a proxy for functional health facilities/services as non-supported health facilities have stopped functioning

Proxy indicator for accessibility and utilization of health services that may reflect the quality of services. It does not measure the coverage of this service, but the average number of visits in a defined population.

Measure for the workload and proxy indicator of the quality of care.

Measles coverage refers to the percentage of children who have received at least one dose of measles-containing vaccine in a given year. This indicator is used for estimating the vaccine coverage of the total EPI strategy. To avoid overestimation, measles vaccination coverage is often used as a proxy since it is usually lower than DPT3 coverage.

Indicators used for estimating the vaccine coverage of the total EPI strategy. To avoid overestimation, measles vaccination coverage is often used as a proxy since it is usually lower than DTP3 coverage.

Proxy measure for the utilization rate of obstetrics services in health facilities and in communities where Village-Trained Midwives are operating. It is a measure of a health system?s ability to provide adequate care for pregnant women during labour and delivery.

The proportion of all deliveries by caesarean section in a geographical area is a measure of access to and use of a common obstetric interventions for averting maternal and neonatal deaths and for preventing complications such as obstetric fistula. Of all the procedures used to treat major obstetric complications, caesarean section is one of the commonest, and reporting is relatively reliable.

Useful measure of the burden of diseases and detect outbreaks. The list of diseases is context specific and can include communicable and non-communicable diseases.

Probability of dying as a result of a given disease. Is a result of a mixture of disease severity and quality of health care.

Prevalence rate (%) of global acute malnutrition in children 6 to 59 months of age based on presence of bilateral pitting oedema and / or weight-for-height z-score less than -2 standard deviations of the median of the standard population (WHO 2006)

Prevalence rate (%) of global acute malnutrition in infants less than 6 months of age based on presence of bilateral pitting oedema and /or weight-for-height z-score less than -2 standard deviations of the median of the standard population (WHO 2006)

Prevalence rate (%) of severe acute malnutrition in children 6 to 59 months of age based on presence of bilateral pitting oedema and / or weight-for-height z-score less than -3 standard deviations of the median of the standard population (WHO 2006)

Prevalence rate (%) of severe acute malnutrition in infants less than 6 months of age based on presence of bilateral pitting oedema and weight-for-height z-score less than -3 standard deviations of the median of the standard population (WHO 2006)

Prevalence rate (%) of moderate acute malnutrition in children 6 to 59 months of age based on presence of weight-for-height z-score less than -2 and equal or greater than -3 standard deviations of the median of the standard population (WHO 2006)

Prevalence rate (%) of moderate acute malnutrition in infants less than 6 months of age based on weight-for-height z-score less than -2 and equal or greater than -3 standard deviations of the median of the standard population (WHO 2006)

Prevalence rate (%) of stunting in children 0 to 59 months of age based on height-for-age z-score less than -2 standard deviations of the median of the standard population (WHO 2006)

Prevalence rate (%) of children 6-59 months with MUAC less than 125 mm and/or having bilateral pitting oedema

Prevalence rate (%) children 6-59 months with MUAC less than 115 mm and/or having bilateral pitting oedema

Prevalence rate (%) children 6-59 months with MUAC less than 125 mm but equal or more than 115 mm

Prevalence rate (%) PLW with MUAC less than 210-230 mm (Note: Countries use a range of different cut-offs depending on resources)

Prevalence rate (%) of women 15-49 years old who have height less than 145 cm

Prevalence rate (%) of adults aged 19.1 to 59.9 years old with BMI less than 17.00 kg/m2 and/or having bilateral pitting oedema